La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Nath Bio-Genes (India) Gestion
Gestion contrôle des critères 1/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Satish Kagliwal
Directeur général
₹6.6m
Rémunération totale
| Pourcentage du salaire du PDG | 100.0% |
| Durée du mandat du directeur général | 25yrs |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | pas de données |
| Durée moyenne du mandat des membres du conseil d'administration | 3.8yrs |
Mises à jour récentes de la gestion
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely
Aug 11
Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14
Recent updates
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely
Aug 11Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Solid Earnings May Rest On Weak Foundations
Jul 31Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Shares Fly 34% But Investors Aren't Buying For Growth
Jul 02These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger
Jun 07Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Feb 11We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business
Jun 19Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)
May 27Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About
Feb 07Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?
Jan 19The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It
Jan 01Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Nov 05Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?
Oct 15Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%
Sep 24Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
Sep 08Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years
Sep 07Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares
Aug 18Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay
Jul 26Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) Likely To Turn Things Around?
Jul 09Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹398m |
| Mar 31 2024 | ₹7m | ₹7m | ₹396m |
| Dec 31 2023 | n/a | n/a | ₹374m |
| Sep 30 2023 | n/a | n/a | ₹379m |
| Jun 30 2023 | n/a | n/a | ₹374m |
| Mar 31 2023 | ₹5m | ₹5m | ₹350m |
| Dec 31 2022 | n/a | n/a | -₹827m |
| Sep 30 2022 | n/a | n/a | -₹813m |
| Jun 30 2022 | n/a | n/a | -₹815m |
| Mar 31 2022 | ₹5m | ₹5m | -₹674m |
| Dec 31 2021 | n/a | n/a | ₹561m |
| Sep 30 2021 | n/a | n/a | ₹575m |
| Jun 30 2021 | n/a | n/a | ₹593m |
| Mar 31 2021 | ₹5m | ₹5m | ₹557m |
| Dec 31 2020 | n/a | n/a | ₹562m |
| Sep 30 2020 | n/a | n/a | ₹558m |
| Jun 30 2020 | n/a | n/a | ₹565m |
| Mar 31 2020 | ₹5m | ₹5m | ₹505m |
| Dec 31 2019 | n/a | n/a | ₹482m |
| Sep 30 2019 | n/a | n/a | ₹478m |
| Jun 30 2019 | n/a | n/a | ₹477m |
| Mar 31 2019 | ₹5m | ₹5m | ₹384m |
| Dec 31 2018 | n/a | n/a | ₹349m |
| Sep 30 2018 | n/a | n/a | ₹353m |
| Jun 30 2018 | n/a | n/a | ₹353m |
| Mar 31 2018 | ₹3m | ₹3m | ₹294m |
Rémunération vs marché: La rémunération totale de Satish ($USD 78.66K ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Indian ($USD 37.60K ).
Rémunération et revenus: La rémunération de Satish a augmenté de plus de 20 % au cours de l'année écoulée.
PDG
Satish Kagliwal (67 yo)
25yrs
Titularisation
₹6,600,000
Compensation
Mr. Satish Kagliwal serves as the Chairman of the Board at Agri-tech (India) Limited and has been its Executive Director since August 30, 1999 & serves as it's Managing Director of Agri-tech (India) Limite...
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| MD & Executive Director | 25yrs | ₹6.60m | pas de données | |
| Executive Director | 5.3yrs | ₹20.00k | 0.0015% ₹ 66.2k | |
| Non-Executive Director | 1.3yrs | ₹15.00k | pas de données | |
| Independent Non-Executive Director | 2.4yrs | ₹20.00k | pas de données | |
| Independent Non-Executive Director | 3.8yrs | ₹20.00k | pas de données | |
| Independent Non-Executive Director | 3.8yrs | ₹23.00k | pas de données | |
| Independent Non-Executive Director | 3.5yrs | ₹23.00k | pas de données |
3.8yrs
Durée moyenne de l'emploi
64yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de NATHBIOGEN sont considérés comme expérimentés (ancienneté moyenne 3.8 ans).